Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000233277 | SCV000290547 | benign | Multiple endocrine neoplasia, type 2 | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000573753 | SCV000674745 | likely benign | Hereditary cancer-predisposing syndrome | 2015-11-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002500810 | SCV002795732 | likely benign | Hirschsprung disease, susceptibility to, 1; Multiple endocrine neoplasia type 2B; Pheochromocytoma; Familial medullary thyroid carcinoma; Multiple endocrine neoplasia type 2A | 2022-01-06 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000233277 | SCV004357250 | likely benign | Multiple endocrine neoplasia, type 2 | 2022-09-29 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000233277 | SCV004819173 | likely benign | Multiple endocrine neoplasia, type 2 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004706682 | SCV005220645 | likely benign | not provided | criteria provided, single submitter | not provided |